Capillary Blood Accuracy
NCT06544070 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2024-08-09
Summary
Entia is a health technology company that has developed a blood testing device called Entia Liberty, which analyses blood collected by a finger prick. Entia is sponsoring this research study to compare the results from Entia Liberty finger prick tests to results from the gold-standard laboratory analyser that tests blood from the arm, port, or PICC line.
Conditions
Interventions
- DEVICE
-
Entia Liberty System
Participants will donate finger-prick blood samples to be tested on the Entia Liberty System. The results will not be used to inform clinical decisions or affect routine clinical care in any way.
Sponsors & Collaborators
-
Entia Ltd
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-11-04
- Primary Completion
- 2025-11-03
- Completion
- 2025-11-03
More Related Trials
-
A First-in-human Trial to Assess the Safety and Performance of the BioCaptis in Healthy Volunteers
NCT05813041 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of e- Ab Sensor - Based Real-time Diagnosis of Serum Procalcitonin Level
NCT01388114 ·Status: COMPLETED ·Phase: NA
-
Capillary-Venous Paired Collection
NCT06183151 ·Status: NOT_YET_RECRUITING
-
A Study to Compare Analytes in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01786408 ·Status: WITHDRAWN ·Phase: NA
-
Liberty Analyzer WBC System: Reference Interval Study
NCT07031882 ·Status: NOT_YET_RECRUITING
-
Clinical Evaluation of i-STAT Analyzer Glucose, Hematocrit and Sodium for Capillary Samples
NCT02897154 ·Status: COMPLETED
-
In Vivo Raman Spectroscopy of Human Capillary Beds
NCT02333136 ·Status: TERMINATED
-
Measuring Alterations of DNA in Human Blood
NCT00178308 ·Status: COMPLETED
-
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
NCT01934842 ·Status: WITHDRAWN ·Phase: NA
-
The Equivalency of the Imp SFB7+ (L-Dex U400) With the Imp XCA Device
NCT00766935 ·Status: COMPLETED
-
Body Water Content Sensor
NCT00643721 ·Status: TERMINATED
-
Assessment of Stability of Mail-in Capillary Hemoglobin A1c Test Kit
NCT00511030 ·Status: COMPLETED
-
Liquid Biopsy System Intracoronary Blood Sampling and Analysis to Characterise Disease Biomarkers in Patients With Coronary Disease
NCT06259019 ·Status: RECRUITING ·Phase: NA
-
Collection of Blood Samples for New Diagnostic Devices 2
NCT05568966 ·Status: RECRUITING ·Phase: NA
-
To Evaluate the Feasibility of Collecting Duodenal Fluid With SIMBA Capsules
NCT06708832 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Research & Evaluation of LumiraDx SARS-CoV-2 (COVID-19) Point of Care Ab Test
NCT04597047 ·Status: UNKNOWN ·Phase: NA
-
Development of a Segmental Bioelectrical Impedance Spectroscopy Device for Body Composition Measurement
NCT04006899 ·Status: COMPLETED
-
Comparison Study for Bioelectrical Impedance Device to Measure Human Body Composition
NCT00956917 ·Status: COMPLETED ·Phase: NA
-
EpiFaith Syringe for Epidural Space Detection
NCT03983109 ·Status: COMPLETED ·Phase: NA
-
Bias Source of Signal in SCOUT DS
NCT01550328 ·Status: TERMINATED
-
Pilot Testing a Novel Non-invasive Lactate Sensor
NCT05649358 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of Capillary Blood Samples Collected Using the Tasso+ Serum Gel Capillary Blood Collection System for Clinical Chemistry Testing of 14 Analytes on an Abbott Alinity Analyzer
NCT07260799 ·Status: RECRUITING
-
Clinical Evaluation of a Novel Wearable Compression Technology in the Treatment of Lymphedema, An Open-Label Controlled Study
NCT04659564 ·Status: COMPLETED ·Phase: NA
-
A Performance Evaluation of the LumiraDx Point of Care CRP Assay
NCT05180110 ·Status: COMPLETED ·Phase: NA
-
OM2 Abbreviated Sensor Verification
NCT06415799 ·Status: COMPLETED